A5046537509- Infectious Diseases and Tuberculosis
- Vasculitis and related conditions
- Ocular Diseases and Behçet’s Syndrome
- Spine and Intervertebral Disc Pathology
- Dermatological and COVID-19 studies
- Hematological disorders and diagnostics
- Tuberculosis Research and Epidemiology
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Systemic Sclerosis and Related Diseases
- Blood disorders and treatments
- Bacterial Infections and Vaccines
- Breast Lesions and Carcinomas
- Diagnosis and treatment of tuberculosis
- Chronic Lymphocytic Leukemia Research
- Autoimmune and Inflammatory Disorders
- Autoimmune and Inflammatory Disorders Research
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Bone and Joint Diseases
- Inflammatory Myopathies and Dermatomyositis
- Spondyloarthritis Studies and Treatments
- Bartonella species infections research
- Parvovirus B19 Infection Studies
- Heparin-Induced Thrombocytopenia and Thrombosis
- Diphtheria, Corynebacterium, and Tetanus
Université d'Orléans
2025
Les Hôpitaux de Chartres
1996-2024
Assistance Publique – Hôpitaux de Paris
2010
Hôpital Européen Georges-Pompidou
2010
Hôpital Cochin
2010
Université Paris Cité
1993-2010
Centre Hospitalier Universitaire de Tours
2010
Université Paris-Est Créteil
2010
Université Sorbonne Paris Nord
2010
Centre hospitalier régional d'Orléans
2006
There is little known about the impact of SARS-CoV-2 on patients with inflammatory rheumatic and musculoskeletal diseases (iRMD). We examined epidemiological characteristics associated severe disease, then death. also compared mortality between hospitalised for COVID-19 without iRMD.Individuals suspected iRMD-COVID-19 were included in this French cohort. Logistic regression models adjusted age sex used to estimate ORs 95% CIs COVID-19. The most significant clinically relevant factors...
Hydroxychloroquine (HCQ) is an important medication for treating systemic lupus erythematosus (SLE). Its blood concentration ([HCQ]) varies widely between patients and a marker predictor of SLE flares. This prospective randomised, double-blind, placebo-controlled, multicentre study sought to compare standard adjusted HCQ dosing schedules that target [HCQ] ≥1000 ng/ml reduce was measured in 573 with (stable disease SELENA-SLEDAI≤12) treated at least 6 months. Patients from 100 750 were...
To examine the course of interstitial lung disease associated with rheumatoid arthritis (RA-ILD) in France on treatment Janus kinase inhibitors (JAKis) using MAJIK-SFR registry. Prospective national multicentre observational study identifying patients RA-ILD from Pulmonary assessment data were collected at JAKi initiation and follow-up visits (6 months, 12 months a median 21 postinclusion), including chest high-resolution CT (HRCT), pulmonary function tests (forced vital capacity (FVC)...
Objectives. To describe pregnancies of women with systemic necrotizing vasculitides (SNVs), i.e. PAN, WG, Churg–Strauss syndrome (CSS) or microscopic polyangiitis (MPA), followed over the past 15 years at four French centres. Methods. Retrospective analysis whose SNV appeared during pregnancy who became pregnant after diagnosis. Results. Among 12 identified, one experienced rupture pancreatic artery microaneurysms 27 weeks revealing leading to surgical haemostasis and caesarean delivery....
Abstract Objective HCQ is an essential medication in SLE, proven to lengthen survival and reduce flares. Its use, however, limited by its rare but severe ophthalmological complications. Here, we aimed analyse factors associated with retinopathy including blood levels. Methods This case–control study compared SLE patients without retinopathy, defined abnormal results for at least two of the following tests: automated visual fields, spectral-domain optical coherence tomography (SD-OCT),...
Patients with rheumatoid arthritis (RA) have an increased risk of cardiovascular (CV) disease. Adiponectin is involved in the metabolism glucose and lipids favourable effects on CV disease, especially its high molecular weight (HMW) isoform. Body composition changes are described RA various phenotypes including obesity. The tocilizumab serum adiponectin body composition, fat mass, patients not well determined.Patients active despite previous csDMARDs and/or bDMARDs who were naïve enrolled a...
Abstract Background Hydroxychloroquine (HCQ) levels can be measured in both serum and whole blood. No cut-off point for non-adherence has been established nor have these methods ever compared. The aims of this study were to compare two approaches determine if HCQ points identify non-adherent patients. Methods blood from 573 patients with systemic lupus erythematosus (SLE). risk factors active SLE (SLEDAI score > 4) identified by multiple logistic regression. Serum 68 additional known...
Introduction: l'objectif de cette étude était d'évaluer la réponse thérapeutique des patients traités par les antirhumatismaux modificateurs maladie (ARMM) pour une polyarthrite rhumatoïde (PR).